We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
Cap. Flow
+$1.35B
Cap. Flow %
3.15%
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$21.8M
2
CVX icon
Chevron
CVX
+$20.5M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$19.7M
4
INCY icon
Incyte
INCY
+$17.8M
5
XOM icon
ExxonMobil
XOM
+$16.9M

Top Sells

Rank Stock Value
1
SE
Spectra Energy Corp Wi
SE
+$49.6M
2
STJ
St Jude Medical
STJ
+$41.1M
3
LLTC
Linear Technology Corp
LLTC
+$30.3M
4
HAR
Harman International Industries
HAR
+$13.8M
5
ENH
Endurance Specialty Holdings Ltd
ENH
+$10.3M

Sector Composition

Rank Sector Weight
1 Financials 16.2%
2 Technology 15.06%
3 Healthcare 13.05%
4 Industrials 10.88%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UONEK icon
2826
Urban One Class D
UONEK
$22.1M
$42K ﹤0.01%
1,275
+93
+8% +$2.67K
ADPT
2827
DELISTED
Adeptus Health Inc
ADPT
$42K ﹤0.01%
23,314
+6,980
+43% +$39.2K
SENS icon
2828
Senseonics Holdings Inc
SENS
$265M
$41K ﹤0.01%
1,147
+53
+5% +$2.56K
ERN
2829
DELISTED
Erin Energy Corp
ERN
$41K ﹤0.01%
17,247
+5,907
+52% +$18.9K
DMTX
2830
DELISTED
Dimension Therapeutics, Inc
DMTX
$40K ﹤0.01%
22,694
+12,667
+126% +$33.6K
VNCE icon
2831
Vince Holding Corp
VNCE
$80.7M
$38K ﹤0.01%
2,443
+708
+41% +$17K
FCEL icon
2832
FuelCell Energy
FCEL
$1.89B
$37K ﹤0.01%
74
+4
+6% +$2.26K
LUB
2833
DELISTED
Luby's Inc.
LUB
$37K ﹤0.01%
11,753
+911
+8% +$3.28K
AMPE
2834
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$29K ﹤0.01%
121
+8
+7% +$2.15K
WAC
2835
DELISTED
Walter Investment Mgt Corp
WAC
$29K ﹤0.01%
27,276
-3,182
-10% -$9.8K
ELDN icon
2836
Eledon Pharmaceuticals
ELDN
$263M
$27K ﹤0.01%
+197
New +$28.9K
AVGR
2837
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
0
– –
TNDM icon
2838
Tandem Diabetes Care
TNDM
$1.3B
$20K ﹤0.01%
1,636
+87
+6% +$1.9K
ANTH
2839
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$15K ﹤0.01%
4,540
+230
+5% +$1.09K
VANI icon
2840
Vivani Medical
VANI
$112M
$13K ﹤0.01%
458
+28
+7% +$1.07K
ARGS
2841
DELISTED
Argos Therapeutics, Inc.
ARGS
$12K ﹤0.01%
+1,339
New +$84.7K
ULU
2842
DELISTED
ULURU INC COM STK NEW (NV)
ULU
$1K ﹤0.01%
22,000
– –
HIFS icon
2843
Hingham Institution for Saving
HIFS
$622M
– –
-1,019
Closed -$201K
SCOR icon
2844
Comscore
SCOR
$112M
– –
-4,563
Closed -$2.88M
XBKS
2845
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
– –
-7,111
Closed -$201K
CBR
2846
DELISTED
CIBER Inc.
CBR
– –
-20,636
Closed -$13K
MENT
2847
DELISTED
Mentor Graphics Corp
MENT
– –
-234,224
Closed -$8.64M
ENH
2848
DELISTED
Endurance Specialty Holdings Ltd
ENH
– –
-111,824
Closed -$10.3M
PLKI
2849
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
– –
-30,003
Closed -$1.81M
SCAI
2850
DELISTED
Surgical Care Affiliates, Inc.
SCAI
– –
-29,939
Closed -$1.39M
112 113
114
115 116

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RhumbLine Advisers's Q1 2017 Portfolio in Review

As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.

  • RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
  • RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
  • RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
  • RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
  • RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
  • RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.

Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.